Registered South Africa · SAHPRA

YSELTY 100 mg

LINZAGOLIX CHOLINE EQUIVALENT TO LINZAGOLIX

60/21.12/0303 nervous system INN generic

What it does

Choline is a nutrient important for various bodily functions, including brain health and liver function.

Commonly used for: supporting brain health, helping with liver function

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
60/21.12/0303
Registration date
2026/10/13
Expiry date
-
Status
Registered
Active ingredient
LINZAGOLIX CHOLINE EQUIVALENT TO LINZAGOLIX
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
N02BA - Salicylic acid and derivatives
Drug group
NERVOUS SYSTEM
RxNorm RxCUI
2449
Manufacturer / MAH
-
Applicant / LTR
Adcock Ingram Limited
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-10-28 04:13:08

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About this medicine

Choline is a nutrient important for various bodily functions, including brain health and liver function.

What it treats

  • supporting brain health
  • helping with liver function

How it works

Choline helps produce important substances in the body, like phospholipids, which are essential for cell membranes.

Who it's for

Choline can be beneficial for people needing support for cognitive function and liver health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: choline

BNF-referenced

Choline is an essential nutrient that plays a critical role in various biological processes, particularly in the maintenance of cell membrane integrity, neurotransmitter synthesis, and lipid metabolism. It is a precursor of acetylcholine, a neurotransmitter vital for nerve conduction and cognitive function. Choline also contributes to the synthesis of phosphatidylcholine and sphingomyelin, important phospholipids in cellular membranes. Inadequate choline intake can lead to several health issues, including liver dysfunction and neurological disorders.

Indications

  • Choline deficiency
  • Support in liver function
  • Neurological health, including cognitive function
  • Fat metabolism disorders

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Choline is a major component of phosphatidylcholine, which is essential for maintaining cell membrane integrity, facilitating information flow, and intracellular communication. It is involved in the synthesis of acetylcholine, a key neurotransmitter in the central nervous system. Choline deficiency can lead to apoptosis by affecting cell membrane composition and increasing ceramide levels, which activates apoptotic pathways. Additionally, choline is a precursor to betaine, which helps regulate homocysteine levels, thus reducing cardiovascular risks.

Pharmacodynamics

Choline is crucial for proper nerve conduction in the central nervous system as it is a precursor for acetylcholine. It supports liver function, gallbladder regulation, and lipid metabolism. Adequate choline levels are associated with the prevention of excessive fat accumulation in the liver and may mitigate conditions such as Parkinsonism and tardive dyskinesia. Deficiencies can lead to serious health problems, including liver dysfunction and stunted growth.

Pharmacokinetics

Choline is absorbed in the intestines and distributed throughout the body, where it is utilized in various metabolic pathways. The liver plays a central role in choline metabolism, converting it into phosphatidylcholine and other metabolites. The half-life and excretion pathways of choline are not well defined but are influenced by dietary intake, physiological state, and individual metabolism.

Interactions

  • corticosteroids+cholinesalicylate: Unknown (decreases concentration)

Pregnancy

Choline is generally considered safe during pregnancy, as it is essential for fetal development, particularly for brain development and function. However, it is important to adhere to recommended dietary allowances.

Breast-feeding

Choline is important during breastfeeding as it supports infant brain development. Adequate intake is recommended for nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: choline

PubChem CID 305

Molecular formula: C5H14NO+

Mechanism of action

Choline is a major part of the polar head group of phosphatidylcholine. Phosphatidylcholine's role in the maintenance of cell membrane integrity is vital to all of the basic biological processes: information flow, intracellular communication and bioenergetics. Inadequate choline intake would negatively affect all these processes. Choline is also a major part of another membrane phospholipid, sphingomyelin, also important for the maintenance of cell structure and function. It is noteworthy and not surprising that choline deficiency in cell culture causes apoptosis or programmed cell death. This appears to be due to abnormalities in cell membrane phosphatidylcholine content and an increase in ceramide, a precursor, as well as a metabolite, of sphingomyelin. Ceramide accumulation, which is caused by choline deficiency, appears to activate Caspase, a type of enzyme that mediates apoptosis. Betaine or trimethylglycine is derived from choline via an oxidation reaction. Betaine is one of the factors that maintains low levels of homocysteine by resynthesizing L-methionine from homocysteine. Elevated homocysteine levels are a significant risk factor for atherosclerosis, as well as other cardiovascular and neurological disorders. Acetylcholine is one of the major neurotransmitters and requires choline for its synthesis. Adequate acetylcholine levels in the brain are believed to be protective against certain types of dementia, including Alzheimer's disease.

Pharmacodynamics

This compound is needed for good nerve conduction throughout the CNS (central nervous system) as it is a precursor to acetylcholine (ACh). Choline is also needed for gallbladder regulation, liver function and lecithin (a key lipid) formation. Choline also aids in fat and cholesterol metabolism and prevents excessive fat build up in the liver. Choline has been used to mitigate the effects of Parkinsonism and tardive dyskinesia. Choline deficiencies may result in excessive build-up of fat in the liver, high blood pressure, gastric ulcers, kidney and liver dysfunction and stunted growth.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: linzagolix

PubChem CID 16656889

Molecular formula: C22H15F3N2O7S

Mechanism of action

Linzagolix is a selective antagonist of the gonadotropin-releasing hormone (GnRH) receptor. It binds competitively to GnRH receptors in the pituitary gland, thereby inhibiting endogenous signaling and, in turn, the hypothalamic-pituitary-gonadal axis. More specifically, this inhibition of GnRH signaling results in the suppression of both luteinizing hormone and follicle-stimulating hormone signaling, the latter of which is responsible for stimulating the production of estrogen in the ovaries. Linzagolix, therefore, indirectly suppresses estrogen production and signaling, making it useful in the management of estrogen-dependent conditions like uterine fibroids.

Pharmacodynamics

The administration of linzagolix results in a dose-dependent suppression of luteinizing hormone and follicle-stimulating hormone, and a subsequent decrease in circulating estradiol concentrations. The median serum estradiol levels across all studied patients was in the range of 20 to 60 pg/mL, and progesterone levels were maintained ≤3.1 ng/mL in 83% of women receiving the 200mg dose of linzagolix and 68% of women receiving the 100mg dose. Linzagolix should be avoided in patients with severe hepatic impairment (Child-Pugh C) and in patients with moderate, severe, or end-stage renal disease (eGFR ≤59 mL/min). Some patients experienced a reduction in bone mineral density, varying from 3 to 8% - patients with an increased risk of fracture or osteoporosis should be monitored closely and should receive regular bone density scans to assess any on-going loss.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.